![logo](https://spiegellab.yale.edu/sites/default/files/ancchembio_1.jpg)
November 1, 2011
The group reports an anti-cancer strategy utilizing antibody-recruiting molecules to target urokinase receptors. Congratulations to Chuck, Pat, and Andrew!
The group reports an anti-cancer strategy utilizing antibody-recruiting molecules to target urokinase receptors. Congratulations to Chuck, Pat, and Andrew!